TürkiyeResearch and clinical trials
Gene therapy given to a patient with severe hemophilia B at Gaziantep University
Based on a single news source or an institutional announcement. The level of scientific evidence is low; check the details with a doctor.
A patient diagnosed with severe hemophilia B received gene therapy at Gaziantep University Hospital. The treatment was given in the Adult Hematology department. It was the fourth hemophilia gene therapy performed at the hospital. According to the statement, the treatment aims for the body to produce factor IX over the long term.
What does it mean for patients and families?
Suitable hemophilia B patients may have less need for regular factor treatment. Who is suitable is assessed at a hemophilia center.
Source
Gaziantep Sabah: Hemofili hastasına gen tedavisi uygulandı
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Hemophilia (A and B)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.